Suppression of calbindin D28K in estrogen-induced hamster renal tumors

Journal of Steroid Biochemistry and Molecular Biology

Volumn 92, Issue 5, 2004, Pages 391-398

  Bhat, Hari K ^a   Epelboym, Irina ^a  

^a Department of Medicine   (United States)

Author keywords

Calbindin; Hormonal carcinogenesis; Oxidative stress; Renal tumors

Indexed keywords

BIOLOGICAL MARKER; BUFFER; CALBINDIN; CALCIUM; COLECALCIFEROL; COMPLEMENTARY DNA; DNA FRAGMENT; ESTRADIOL; ESTROGEN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CARCINOGENESIS; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HAMSTER; INTERMETHOD COMPARISON; KIDNEY TUMOR; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROTEIN BINDING; RNA ISOLATION; TIME;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CLONING, MOLECULAR; CRICETINAE; DNA, COMPLEMENTARY; ESTROGENS; HUMANS; KIDNEY NEOPLASMS; MALE; MESOCRICETUS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER;

CRICETINAE;

EID: 13244295677     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.07.009     Document Type: Article

References (55)

1. P.G. Toniolo, M. Levitz, A. Zeleniuch-Jacquotte, S. Banerjee, K.L. Koenig, R.E. Shore, P. Strax, and B.S. Pasternack A prospective study of endogenous estrogens and breast cancer in postmenopausal women J. Natl. Cancer Inst. 87 1995 190 197
2. J.L. Kelsey, M.D. Gammon, and E.M. John Reproductive factors and breast cancer Epidemiol. Rev. 15 1993 36 47
3. The Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer Lancet 350 1997 1047 1059
4. Report on Carcinogens, tenth ed., U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, December 2002.
5. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
6. H. Kirkman Estrogen-induced tumors of the kidney. Growth characteristics in the Syrian hamster Natl. Cancer Inst. Monogr. 1 1959 1 57
7. H.K. Bhat, G. Calaf, T.K. Hei, T. Loya, and J.V. Vadgama Critical role of oxidative stress in estrogen-induced carcinogenesis Proc. Natl. Acad. Sci. USA 100 2003 3913 3918
8. J.D. Shull, T.J. Spady, M.C. Snyder, S.L. Johansson, and K.L. Pennington Ovary-intact but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma Carcinogenesis 18 1997 1595 1601
9. B.T. Zhu, D. Roy, and J.G. Liehr The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites Endocrinology 132 1993 577 583
10. X. Han, and J.G. Liehr 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis Cancer Res. 54 1994 5515 5517
11. T. Tsutsui, Y. Tamura, E. Yagi, and J.C. Barrett Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17β-estradiol and eight of its metabolites Int. J. Cancer. 86 2000 8 14
12. J.G. Liehr, and D.A. Sirbasku Estrogen-dependent kidney tumors M. Taub Tissue Culture of Epithelial Cells 1985 Plenum Press New York, NY 205 234
13. J.G. Liehr Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters Environ. Health Perspect. 105 1997 565 569
14. J.J. Li, S.A. Li, T.D. Oberley, and J.A. Parson Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation Cancer Res. 55 1995 4347 4351
15. J.G. Liehr, G.M. Stancel, L.P. Chorich, G.R. Bousfield, and A.A. Ulubelen Hormonal carcinogenesis: separation of estrogenicity from carcinogenicity Chem. Biol. Interact. 59 1986 173 184
16. A.A. Yuzpe Oral contraception: trends over time J. Reprod. Med. 47 2002 967 973
17. M.M. Patel, and H.K. Bhat Differential oxidant potential of carcinogenic and weakly carcinogenic estrogens: involvement of metabolic activation and cytochrome P450 J. Biochem. Mol. Toxicol. 18 2004 37 42
18. B.T. Zhu, and A.H. Conney Functional role of estrogen metabolism in target cells: review and perspectives Carcinogenesis 19 1998 1 27
19. J.G. Liehr, and D. Roy Free radical generation by redox cycling of estrogens Free Radic. Biol. Med. 8 1990 415 423
20. J.D. Yager Endogenous estrogens as carcinogens through metabolic activation J. Natl. Cancer Inst. Monogr. 27 2000 67 73
21. S. Chistakos, C. Gabrielides, and W.B. Rhoten Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations and molecular biology Endocr. Rev. 10 1989 3 26
22. A. Gagnon, and J. Welsh Modulation and phosphorylation of calbindin-D28K correlates with protein kinase C activation 1 Biochem. Cell. Biol. 75 1997 33 40
23. J. Hugon, F. Hugon, F. Esclaire, M. Lesort, and A.G. Diop The presence of calbindin in rat cortical neurons protects in vitro from oxidative stress Brain Res. 29 1996 288 292
24. Q. Guo, S. Christakos, N. Robinson, and M.P. Mattson Calbindin-D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function Proc. Natl. Acad. Sci. USA 95 1998 3227 3232
25. H.K. Bhat, H.J. Hacker, P. Bannasch, E.A. Thompson, and J.G. Liehr Localization of estrogen receptors in interstitial cells of hamster kidney and in estradiol-induced renal tumors as evidence of the mesenchymal origin of this neoplasm Cancer Res. 53 1993 5447 5451
26. P. Chomzynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
27. L.M. Everett, A. Li, G. Devaraju, A. Caperell-Grant, and R.M. Bigsby A novel estrogen-enhanced transcript identified in the rat uterus by differential display Endocrinology 138 1997 3836 3841
28. P. Liang, and A.B. Pardee Differential display of eukaryotic messenger RNA by means of polymerase chain reaction Science 257 1992 967 971
29. S.P. Bhat DNA sequencing on minigels: an alternative technique for routine analysis Anal. Biochem. 212 1993 560 562
30. M. McClelland, K. Chada, J. Welsh, and D. Ralph Arbitrary primed PCR fingerprinting of RNA applied to mapping differentially expressed genes EXS 67 1993 103 115
31. H.K. Bhat, and J.V. Vadgama Hamster estrogen receptor cDNA: cloning and mRNA expression J. Steroid Biochem. Mol. Biol. 72 2000 47 53
32. H.K. Bhat, W.R. Hiatt, C.R. Hoppel, and E.P. Brass Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease Circulation 99 1999 807 812
33. N. Lomri, C. Perret, N. Gouhier, and M. Thomasset Cloning and analysis of calbindin-D28K cDNA and its expression in the central nervous system Gene 80 1989 87 98
34. W. Hunziker, and S. Schrickel Rat brain calbindin D28: six-domain structure and extensive amino acid homology with chicken calbindin D28 Mol. Endocrinol. 2 1988 465 473
35. T.L. Wood, Y. Kobayashi, G. Frantz, S. Varghese, S. Cristakos, and A.J. Tobin Molecular cloning of mammalian 28,000 Mr Vitamin D-dependent calcium binding protein (calbindin-D28K): expression of calbindin-D28K RNAs in rodent brain and kidney DNA 7 1988 585 593
36. P.R. Turner, S. Mefford, S. Christakos, and R.A. Nissenson Apoptosis mediated by activation of the G protein-coupled receptor for PTH/PTHrP in UMR106 osteoblastic cells Am. J. Physiol. Endocrinol. Metab. 281 2000 E162 E170
37. J. Kishimoto, T. Tsuchiya, H. Cox, P.C. Emerson, and Y. Nakayama Age-related changes of calbindin-D28k, calretinin, and parvalbumin mRNAs in the hamster brain Neurobiol. Aging 19 1998 77 82
38. C. Geula, J. Bu, N. Nagykery, L.F. Scinto, J. Chan, J. Joseph, R. Parker, and C.K. Wu Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss J Comp. Neurol. 455 2003 249 259
39. L.A. Opperman, T.J. Saunders, D.E. Bruns, J.C. Boyd, S.E. Mills, and M.E. Bruns Estrogen inhibits calbindin-D28k expression in mouse uterus Endocrinology 130 1992 1728 1735
40. R.K. Gill, and S. Christakos Regulation by estrogen through the 5′-flanking region of the mouse calbindin-D28k gene Mol. Endocrinol. 9 1995 319 326
41. J.G. Liehr Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev. 21 2000 40 54
42. M.B. Lipsett, G.R. Merriam, S. Kono, D.D. Brandon, D.G. Pfeiffer, and D.L. Loriaux Metabolic clearance of catechol estrogens G.R. Merriam M.B. Lipsett Catechol Estrogens 1983 Raven Press New York, NY 105 114
43. G. Emons, G.R. Merriam, D. Pfeiffer, D.L. Loriaux, P. Ball, and R. Knuppen Metabolism of exogenous 4- and 2-hydroxyestradiol in the human male J. Steroid Biochem. 28 1987 499 504
44. J. Weisz, Q.D. Bui, D. Roy, and J.G. Liehr Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens Endocrinology 131 1992 655 661
45. B.T. Zhu, and J.G. Liehr Inhibition of the catechol-O-methyltransferase- catalyzed O-methylation of 2- and 4-hydroxyestradiol by catecholamine: implications for the mechanism of estrogen-induced carcinogenesis Arch. Biochem. Biophys. 304 1993 248 256
46. D. Roy, J. Weisz, and J.G. Liehr The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis Carcinogenesis 11 1990 459 462
47. J.G. Liehr, W.F. Fang, D.A. Sirbasku, and A. Ari-Ulubelen Carcinogenicity of catechol estrogens in Syrian hamsters J. Steroid Biochem. 24 1986 353 356
48. R.R. Newbold, and J.G. Liehr Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens Cancer Res. 60 2000 235 237
49. D. Roy, and J.G. Liehr Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. Increased superoxide formation by redox cycling of estrogen J. Biol. Chem. 263 1988 3646 3651
50. A. Rabinovitch, W.L. Suarez-Pinzon, K. Sooy, K. Strynadka, and S. Christakos Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis Endocrinology 142 2001 3649 3655
51. M.J. Wu, L.W. Lai, and Y.H. Lien Cytoprotective effects of calbindin-D28k against antimycin-A induced hypoxic injury in proximal tubular cells Life Sci. 71 2002 559 569
52. M.A. Yenari, M. Minami, G.H. Sun, T.J. Meier, D.M. Kunis, J.R. McLaughlin, D.Y. Ho, R.M. Sapolsky, and G.K. Steinberg Calbindin-D28k overexpression protects striatal neurons from transient focal cerebral ischemia Stroke 32 2001 1028 1035
53. C.Y. Castro, M. Stephenson, M.M. Gondo, L.J. Medeiros, and P.T. Cagle Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases Mod. Pathol. 13 2000 808 813
54. H. Watanbe, M. Imaizumi, T. Ojika, T. Abe, T. Hida, and K. Kato Evaluation of biological characteristics of lung cancer by the human 28 kDa Vitamin D-dependent calcium binding protein, calbindin-D28k Jpn. J. Clin. Oncol. 24 1994 121 127
55. C.D. Katsetos, M.M. Jami, L. Krishna, R. Jackson, A.S. Patchefsky, and H.S. Cooper Novel immunohistochemical localization of 28,000 molecular weight (Mr) calcium binding protein (calbindin-D28k) in enterochromaffin cells of the human appendix and neuroendocrine tumors (carcinoids and small-cell carcinomas) of the midgut and foregut Arch. Pathol. Lab. Med. 118 1994 633 639